Evidence map›Paper›PMID 41757932›Full record

ArticleMicrobiology spectrum2026

Detection of OXA-23 and OXA-58 in

Janina Noster-Schrader, Janko Sattler, Yvonne Stoll, Martina Spille, Andreas Rump, Stephan Göttig, Sören Gatermann, Axel Hamprecht

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Janina Noster-SchraderCarl von Ossietzky University Oldenburg, Institute of Medical Microbiology and Virology, Oldenburg, Germany.ORCID 0000-0002-8802-6605
Janko SattlerGerman Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany.ORCID 0000-0003-1415-4169
Yvonne StollCarl von Ossietzky University Oldenburg, Institute of Medical Microbiology and Virology, Oldenburg, Germany.
Martina SpilleCarl von Ossietzky University Oldenburg, Institute of Medical Microbiology and Virology, Oldenburg, Germany.
Andreas RumpDepartment of Medical Genetics, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
Stephan GöttigGoethe University Frankfurt, University Hospital, Institute of Medical Microbiology and Infection Control, Frankfurt am Main, Germany.ORCID 0000-0001-6896-5309
Sören GatermannNational Reference Laboratory for Multidrug-Resistant Gram-negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
Axel HamprechtCarl von Ossietzky University Oldenburg, Institute of Medical Microbiology and Virology, Oldenburg, Germany.ORCID 0000-0003-1449-5780

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IMPORTANCE: OXA-23 and OXA-58 are among the most frequent carbapenemases in

Indexed as

Bacterial Proteinsbeta-LactamasesChromatography, AffinityProteus mirabilisHumansMicrobial Sensitivity TestsProteus InfectionsSensitivity and SpecificityBacterial Proteinsbeta-lactamase OXA-23beta-LactamasescarbapenemaseAcinetobacter spp.Coris RESIST ACINETO assaylateral flow assayOXA-23OXA-58Proteus spp.

Identifiers

PMID41757932
PMCPMC13055382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.